- Home
- CTNT vs NCNA Comparison
CTNT vs NCNA Comparison
Compare CTNT & NCNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTNT
- NCNA
- Stock Information
- Founded
- CTNT 2016
- NCNA 1997
- Country
- CTNT United States
- NCNA United Kingdom
- Employees
- CTNT N/A
- NCNA N/A
- Industry
- CTNT
- NCNA Biotechnology: Pharmaceutical Preparations
- Sector
- CTNT
- NCNA Health Care
- Exchange
- CTNT Nasdaq
- NCNA Nasdaq
- Market Cap
- CTNT 5.0M
- NCNA 4.5M
- IPO Year
- CTNT 2023
- NCNA 2017
- Fundamental
- Price
- CTNT $1.34
- NCNA $0.05
- Analyst Decision
- CTNT
- NCNA Buy
- Analyst Count
- CTNT 0
- NCNA 2
- Target Price
- CTNT N/A
- NCNA $25.00
- AVG Volume (30 Days)
- CTNT 1.7M
- NCNA 311.0M
- Earning Date
- CTNT 08-12-2025
- NCNA 08-14-2025
- Dividend Yield
- CTNT N/A
- NCNA N/A
- EPS Growth
- CTNT N/A
- NCNA N/A
- EPS
- CTNT N/A
- NCNA N/A
- Revenue
- CTNT $858,770.00
- NCNA N/A
- Revenue This Year
- CTNT $302.80
- NCNA N/A
- Revenue Next Year
- CTNT $22.22
- NCNA N/A
- P/E Ratio
- CTNT N/A
- NCNA N/A
- Revenue Growth
- CTNT N/A
- NCNA N/A
- 52 Week Low
- CTNT $1.12
- NCNA $0.03
- 52 Week High
- CTNT $9.71
- NCNA $10.79
- Technical
- Relative Strength Index (RSI)
- CTNT 48.43
- NCNA 38.00
- Support Level
- CTNT $1.12
- NCNA $0.06
- Resistance Level
- CTNT $1.38
- NCNA $0.10
- Average True Range (ATR)
- CTNT 0.09
- NCNA 0.02
- MACD
- CTNT 0.01
- NCNA 0.00
- Stochastic Oscillator
- CTNT 76.79
- NCNA 0.97
About CTNT Cheetah Net Supply Chain Service Inc.
Cheetah Net Supply Chain Service Inc is a one-stop services including Warehousing, Logistics, International trading & Supply Chain Finance, Etc. It operate in single segment Logistics and warehousing services which focuses on providing freight forwarding services for clients shipping goods from the U.S. to mainland China or Hong Kong. Its services include: (i) cargo storage, (ii) freight forwarding, (iii) U.S. customs clearance, and (iv) labor services and cargo loading and unloading.
About NCNA NuCana plc
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.